Full List Of Stories
Broker tips: GSK, Breedon
Citi has upgraded its rating on vaccines and drugs blue chip GSK to 'buy' while also boosting its earnings estimates, basing its decision on "compelling" data about Blenrep, the group's novel treatment for multiple myeloma, as well as a range of other positive indicators.
Director dealings: Good Energy chairman snaps up shares
Good Energy revealed on Tuesday that chairman William Whitehorn had purchased 5,000 ordinary shares in the AIM-listed renewable electricity company.
US open: Stocks lower following hotter-than-expected CPI reading
Wall Street stocks were sharply lower early on Tuesday as market participants digested a slightly hotter-than-expected January inflation reading.
US inflation rises faster than thought in January
Inflation rose at a faster-than-expected rate in January, according to the Bureau of Labor Statistics, with shelter prices accounting for much of the increase.
US pre-open: Futures lower ahead of CPI reading
Wall Street futures were in the red ahead of the bell on Tuesday as market participants awaited a reading of last month's all-important consumer price index to try and gauge what the Federal Reserve's next moves may be.
Jadestone Energy eyes reverse takeover deal
Upstream company Jadestone Energy said on Tuesday that it was working on a reverse takeover deal that would see it acquire assets owned by Woodside Energy in Australia.
Empyrean raises £700k through share placing
Oil and gas development company Empyrean has raised £700,000 through a placing of 280. 0m new ordinary shares at a price of 0. 25p each.
Mediazest secures 'substantial new business win'
Audio-visual solutions group Mediazest has scored a "substantial new business win" with a "large" UK-based FTSE-listed client.